Pregnenolone Is The Most Potent Inhibitor Of The Stress Signal (CRH)

OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe
You now another thing haidut I'm going have the FDA do a little surprise visit to your trailer park manufacturing plant you've got going on. Let's see if it's up to snuff with the FDA guidelines and GMP rules. Cause from the looks of things I'm sure they can find a lot of things wrong. The ole FDA loves to send their goons out to supplement companies.

https://www.fda.gov/Food/DietarySupplements/ReportAdverseEvent/

Please be careful with the threats of sending "goons" over to raid anybody. I am pretty sure it is not quite legal in most states.
People report adverse events openly on the forum, as per FDA's rules. Obviously, they are free to report directly to FDA as well.
 

Mukem

Member
Joined
Nov 22, 2017
Messages
35
What to make of Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. - PubMed - NCBI ?

Depression is characterized by hypothalamo-pituitary-adrenocortical (HPA) axis hyperactivity. In this major mood disorder, neurosteroids and neurotrophins, particularly brain-derived neurotrophic factor (BDNF), seem to be implicated and have some antidepressant effects. BDNF is highly involved in regulation of the HPA axis, whereas neurosteroids effects have never been clearly established. In this systematic in vivo study, we showed that the principal neuroactive steroids, namely dehydroepiandrosterone (DHEA), pregnenolone (PREG) and their sulfate esters (DHEA-S and PREG-S), along with allopregnanolone (ALLO), stimulated HPA axis activity, while also modulating central BDNF contents. In detail, DHEA, DHEA-S, PREG, PREG-S and ALLO induced corticotropin-releasing hormone (CRH) and/or arginine vasopressin (AVP) synthesis and release at the hypothalamic level, thus enhancing plasma adrenocorticotropin hormone (ACTH) and corticosterone (CORT) concentrations. This stimulation of the HPA axis occurred concomitantly with BDNF modifications at the hippocampus, amygdala and hypothalamus levels. We showed that these neurosteroids induced rapid effects, probably via neurotransmitter receptors and delayed effects perhaps after metabolization in other neuroactive steroids. We highlighted that they had peripheral effects directly at the adrenal level by inducing CORT release, certainly after estrogenic metabolization. In addition, we showed that, at the dose used, only DHEA, DHEA-S and PREG-S had antidepressant effects. In conclusion, these results highly suggest that part of the HPA axis and antidepressant effects of neuroactive steroids could be mediated by BDNF, particularly at the amygdala level. They also suggest that neurosteroids effects on central BDNF could partially explain the trophic properties of these molecules.

preg.png
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe

I have seen it before but considering the humans studies showing allopregnanolone potently inhibits HPA then I am not sure how relevant its findings are to humans. The sulfate esters in very high amounts acts as GABA antagonists and may increase cortisol through this mechanism but I don't think this is relevant for most people. Also, in the picture you attached pregnenolone lowered CRH, so not sure why they say in the abstract it raises CRH.
 

Mukem

Member
Joined
Nov 22, 2017
Messages
35
I have seen it before but considering the humans studies showing allopregnanolone potently inhibits HPA then I am not sure how relevant its findings are to humans. The sulfate esters in very high amounts acts as GABA antagonists and may increase cortisol through this mechanism but I don't think this is relevant for most people. Also, in the picture you attached pregnenolone lowered CRH, so not sure why they say in the abstract it raises CRH.

Ray responded that the method of administration (IP) made the study irrelevant.
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe
Ray responded that the method of administration (IP) made the study irrelevant.

Did he say what method of administration is preferable and why this one is bad?
 

Mukem

Member
Joined
Nov 22, 2017
Messages
35
Did he say what method of administration is preferable and why this one is bad?

He cited your study, called the method stressful. I commented on the drop in CRH and pointed out that they also used a sham ("so don't you think it's unlikely to be an effect of the injection itself?") :

No, I think the stress related results of an intraperitoneal injection are meaningful only in relation to describing methods that shouldn’t be used for investigating normal physiological processes. It’s remarkable that four university endocrinologists would have ignored that point of classical endocrinology procedure.
 

vulture

Member
Joined
Sep 1, 2017
Messages
1,027
I think this study should finally put to rest the arguments and debates of whether pregnenolone raises or lowers cortisol, and how it affects the stress response overall. I posted a similar study, which showed that the pregnenolone metabolites progesterone and allopregannolone potently inhibited ACTH release and thus cortisol synthesis.
Pregnenolone Does Not Boost Cortisol, It Lowers It By 60%

CRH (CRF) is the first step in the manifestation of the stress response. It is a hormone produced in the hypothalamus whenever the organism is under stress, and elevations of CRF/CRH signal the pituitary to produce ACTH, and ACTH signals the adrenals to produce cortisol. Elevated levels of CRF/CRH are found in many diseases, especially "mood" disorders like depression, schizophrenia, PTSD, anxiety, etc. It is well-known that the GABA-ergic system in the brain is one of the natural inhibitors of CRH release and this principle is currently applied in using GABA agonist drugs for treating stress conditions and diseases like Cushing that are characterized by high levels of cortisol.
This study looked at the effect of several steroids on the levels of CRF/CRH. The steroids under study included pregnenolone, allopregnanolone, THDOC, DHEA, and the sulfated derivatives pregnenolone sulfate, and dhea sulfate.
It is already well-known that allopregnanolone and THDOC, both being potent GABA agonists, inhbit CRF/CRH release. What the study found surprising was that pregnenolone itself was the most potent inhibitor of CRF/CRH and it has those effects in relatively low concentrations of 1uM - 30uM range. For the purposes of estimating effects in humans, it is brain levels of pregnenolone that would matter given that CRF/CRH is produced in the brain. Brain levels of pregnenolone are on the order of 100-fold higher than serum levels. I posted a human study in the Pansterone thread showing that a single oral dose of 175mg pregnenolone produced serum levels of 0.5uM in humans and it kept those levels for up to 24 hours. This suggests that the 175mg dose produced brain concentrations of about 50uM. So, to achieve the 30uM concentration found to be most effective for lowering CRF/CRH in the study, one would need about 100mg pregnolone (assuming linear scaling). As many of you here know, Ray has consistently recommended 100mg - 150mg of pregnenolone as a good dose for inhibiting stress, and improving overall health. Given the almost complete absense of studies on pregnenolone bioavailability and pharmacokinetics in humans, the ability of Ray to predict proper dosages of these substances (often decades in advance) is simply astounding!!
One last thing of note is that the steroid allopregnanolone investigated in the study as well is a metabolite of pregnenolone through the progesterone pathways and the activity of the enzyme 5-AR. The scientists suspected that pregnenolone may be inhibiting CRF/CRH through its conversion into allopregnanolone, so they also used the drug finasteride in combination with pregnenolone in order to block its conversion into allopreganolone. Pregnenolone still has the same strong inhibitory effect on CRF/CRH, which means its anti-stress action is intrinsic. That being said, by converting into allopregnanolone as well, pregnenolone may have double anti-stress action - once as an intrinsic effect of pregnenolone, and a second one through the GABA-ergic system activated by its metabolite allopreganolone.
So, pregnenolone is accumulating more and more evidence as one of the primary tools for lowering stress and improving overall health, especially in the brain. Ray recommended to one person over email to combine aspirin and pregnenolone as a potent method to lower cortisol and increase testosterone. I already posted on the ability of aspirin to lower cortisol and increase testosterone on its own, so once again Ray is right on the money.
Aspirin Decreases Cortisol And Increases Testosterone In Humans

Finally, the stress-inhibiting effect of pregnenolone, combined with its ability to raise metabolism, and lower estrogen/cortisol, make it a prime candidate for treating not only mental conditions but also the so-called metabolic syndrome and especially obesity. Both of the latter are conditions almost entirely driven by the CRF/CRH-ACTH-cortisol-estrogen cascade.
Pregnenolone For Obesity And Insulin Resistance
How Pregnenolone And Progesterone Raise Metabolism
Pregnenolone (should) lower estrogen levels

OK, enough of my rant:) Here is the actual study.

Effects of neurosteroids on the human corticotropin-releasing hormone gene. - PubMed - NCBI
"...Corticotropin-releasing hormone (CRH), a peptide synthesized mainly in the paraventricular nuclei (PVN) of the hypothalamus, is a key regulator of hypothalamic-pituitary-adrenal (HPA) axis activity during stress. CRH via pituitary adrenocorticotropic hormone (ACTH) stimulates glucocorticoid synthesis and release from adrenal glands. In turn, glucocorticoids inhibit production of CRH in PVN and ACTH in pituitary by a feedback mechanism. CRH hypersecretion in the central nervous system (CNS) is thought to be an important factor in pathogenesis of some stress-related diseases, such as major depressive disorders, post-traumatic stress disorder (PTSD) or panic disorder [34, 39, 42, 55]. The elevated CRH concentrations in the cerebrospinal fluid and the increased number of CRH-expressing neurons in the hypothalamus have been found in depressed patients [29, 37]. Similarly, the increased CRH concentration or dysregulation of cortisol secretion has been observed in patients with PTSD and panic disorders [11,42]. Also in experimental animals, central administration of CRH or overproduction of this peptide in transgenic mice evoked anxiety, depression, and schizophrenia-like behavior [3, 12, 47]. A large number of preclinical studies have indicated that anxiety-like behavior results from the action of CRH through CRH1 receptor."

"...Apart from CRH1 receptor blockade, another possibility of limiting CRH effect could involve repression of the synthesis of this peptide. Interestingly, although CRH synthesis is augmented by many neurotransmitters and neuropeptides, only two major mechanisms are known to inhibit the HPA axis activity, namely the glucocorticoid negative feedback and the gaminobutyric acid (GABA) [17]. Among compounds acting on GABA receptors, neurosteroids deserve the special attention. Neurosteroids are precursors or metabolites of steroid hormones, which do not show affinities for intracellular steroid hormone receptors, but modulate the action of some membrane receptors, such as GABA, NMDA and sigma-1 [24, 45]. Steroid metabolites with hydroxyl group in the position 3 and with reduced ring A, i.e., allopregnanolone (3a-hydroxy-5a-pregnan20-one, ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are among the most potent allosteric positive modulators of the GABA receptors and exert anxiolytic and antiepileptic activity [7, 9]. Concentrations of ALLO and THDOC are increased in plasma and CNS in response to acute stress and that leads to effect HPA axis activity [14, 36]. Moreover, ALLO and THDOC attenuate the anxiogenic activity of CRH and the methoxamine-stimulated CRH release [33]. Contrary to acute stress, chronic stress decreases brain ALLO concentration and disturbs negative feedback mechanism of HPA regulation."

"...The excitatory neurosteroid, PGL [pregnenolone] potently and in a concentration-dependent manner (0.3–30 μM) inhibited CRH-CAT activity, whereas its sulfate form was active only at high (30 μM) concentration (Fig. 2A and 2B). Similarly as basal activity, also forskolin-stimulated gene transcription was potently inhibited by PGL (1–30 μM), while PGL-S was inactive in these concentrations (Fig. 2C and 2B)."

"...The 5a-reductase inhibitor – finasteride, at 0.1 and 1 μM did not change the basal CAT activity and had no effect on PGL (1 μM) inhibition of CRH gene promoter activity (Fig. 5)."

"...In the present study, we found that some neurosteroids in a concentration-dependent manner inhibited CRH gene promoter activity in the differentiated Neuro-2A cells. Among investigated neurosteroids, PGL [pregnenolone], the main precursor of steroid hormones, exerted the most potent effect. ALLO and THDOC, two potent endogenous positive modulators of the GABA receptors had only a little weaker inhibitory effect than PGL on CRH activity. It is likely that the inhibitory effect of ALLO and THDOC on CRH gene transcription may be implicated in the mechanism of their anxiolytic action."
As long as I know cacao is not the same as cocoa. So, what are we talking about? Cacao or Cocoa? how big is the difference regarding Peaty effects?
 

Maggiemccall

Member
Joined
Sep 21, 2013
Messages
15
I think this study should finally put to rest the arguments and debates of whether pregnenolone raises or lowers cortisol, and how it affects the stress response overall. I posted a similar study, which showed that the pregnenolone metabolites progesterone and allopregannolone potently inhibited ACTH release and thus cortisol synthesis.
Pregnenolone Does Not Boost Cortisol, It Lowers It By 60%

CRH (CRF) is the first step in the manifestation of the stress response. It is a hormone produced in the hypothalamus whenever the organism is under stress, and elevations of CRF/CRH signal the pituitary to produce ACTH, and ACTH signals the adrenals to produce cortisol. Elevated levels of CRF/CRH are found in many diseases, especially "mood" disorders like depression, schizophrenia, PTSD, anxiety, etc. It is well-known that the GABA-ergic system in the brain is one of the natural inhibitors of CRH release and this principle is currently applied in using GABA agonist drugs for treating stress conditions and diseases like Cushing that are characterized by high levels of cortisol.
This study looked at the effect of several steroids on the levels of CRF/CRH. The steroids under study included pregnenolone, allopregnanolone, THDOC, DHEA, and the sulfated derivatives pregnenolone sulfate, and dhea sulfate.
It is already well-known that allopregnanolone and THDOC, both being potent GABA agonists, inhbit CRF/CRH release. What the study found surprising was that pregnenolone itself was the most potent inhibitor of CRF/CRH and it has those effects in relatively low concentrations of 1uM - 30uM range. For the purposes of estimating effects in humans, it is brain levels of pregnenolone that would matter given that CRF/CRH is produced in the brain. Brain levels of pregnenolone are on the order of 100-fold higher than serum levels. I posted a human study in the Pansterone thread showing that a single oral dose of 175mg pregnenolone produced serum levels of 0.5uM in humans and it kept those levels for up to 24 hours. This suggests that the 175mg dose produced brain concentrations of about 50uM. So, to achieve the 30uM concentration found to be most effective for lowering CRF/CRH in the study, one would need about 100mg pregnolone (assuming linear scaling). As many of you here know, Ray has consistently recommended 100mg - 150mg of pregnenolone as a good dose for inhibiting stress, and improving overall health. Given the almost complete absense of studies on pregnenolone bioavailability and pharmacokinetics in humans, the ability of Ray to predict proper dosages of these substances (often decades in advance) is simply astounding!!
One last thing of note is that the steroid allopregnanolone investigated in the study as well is a metabolite of pregnenolone through the progesterone pathways and the activity of the enzyme 5-AR. The scientists suspected that pregnenolone may be inhibiting CRF/CRH through its conversion into allopregnanolone, so they also used the drug finasteride in combination with pregnenolone in order to block its conversion into allopreganolone. Pregnenolone still has the same strong inhibitory effect on CRF/CRH, which means its anti-stress action is intrinsic. That being said, by converting into allopregnanolone as well, pregnenolone may have double anti-stress action - once as an intrinsic effect of pregnenolone, and a second one through the GABA-ergic system activated by its metabolite allopreganolone.
So, pregnenolone is accumulating more and more evidence as one of the primary tools for lowering stress and improving overall health, especially in the brain. Ray recommended to one person over email to combine aspirin and pregnenolone as a potent method to lower cortisol and increase testosterone. I already posted on the ability of aspirin to lower cortisol and increase testosterone on its own, so once again Ray is right on the money.
Aspirin Decreases Cortisol And Increases Testosterone In Humans

Finally, the stress-inhibiting effect of pregnenolone, combined with its ability to raise metabolism, and lower estrogen/cortisol, make it a prime candidate for treating not only mental conditions but also the so-called metabolic syndrome and especially obesity. Both of the latter are conditions almost entirely driven by the CRF/CRH-ACTH-cortisol-estrogen cascade.
Pregnenolone For Obesity And Insulin Resistance
How Pregnenolone And Progesterone Raise Metabolism
Pregnenolone (should) lower estrogen levels

OK, enough of my rant:) Here is the actual study.

Effects of neurosteroids on the human corticotropin-releasing hormone gene. - PubMed - NCBI
"...Corticotropin-releasing hormone (CRH), a peptide synthesized mainly in the paraventricular nuclei (PVN) of the hypothalamus, is a key regulator of hypothalamic-pituitary-adrenal (HPA) axis activity during stress. CRH via pituitary adrenocorticotropic hormone (ACTH) stimulates glucocorticoid synthesis and release from adrenal glands. In turn, glucocorticoids inhibit production of CRH in PVN and ACTH in pituitary by a feedback mechanism. CRH hypersecretion in the central nervous system (CNS) is thought to be an important factor in pathogenesis of some stress-related diseases, such as major depressive disorders, post-traumatic stress disorder (PTSD) or panic disorder [34, 39, 42, 55]. The elevated CRH concentrations in the cerebrospinal fluid and the increased number of CRH-expressing neurons in the hypothalamus have been found in depressed patients [29, 37]. Similarly, the increased CRH concentration or dysregulation of cortisol secretion has been observed in patients with PTSD and panic disorders [11,42]. Also in experimental animals, central administration of CRH or overproduction of this peptide in transgenic mice evoked anxiety, depression, and schizophrenia-like behavior [3, 12, 47]. A large number of preclinical studies have indicated that anxiety-like behavior results from the action of CRH through CRH1 receptor."

"...Apart from CRH1 receptor blockade, another possibility of limiting CRH effect could involve repression of the synthesis of this peptide. Interestingly, although CRH synthesis is augmented by many neurotransmitters and neuropeptides, only two major mechanisms are known to inhibit the HPA axis activity, namely the glucocorticoid negative feedback and the gaminobutyric acid (GABA) [17]. Among compounds acting on GABA receptors, neurosteroids deserve the special attention. Neurosteroids are precursors or metabolites of steroid hormones, which do not show affinities for intracellular steroid hormone receptors, but modulate the action of some membrane receptors, such as GABA, NMDA and sigma-1 [24, 45]. Steroid metabolites with hydroxyl group in the position 3 and with reduced ring A, i.e., allopregnanolone (3a-hydroxy-5a-pregnan20-one, ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are among the most potent allosteric positive modulators of the GABA receptors and exert anxiolytic and antiepileptic activity [7, 9]. Concentrations of ALLO and THDOC are increased in plasma and CNS in response to acute stress and that leads to effect HPA axis activity [14, 36]. Moreover, ALLO and THDOC attenuate the anxiogenic activity of CRH and the methoxamine-stimulated CRH release [33]. Contrary to acute stress, chronic stress decreases brain ALLO concentration and disturbs negative feedback mechanism of HPA regulation."

"...The excitatory neurosteroid, PGL [pregnenolone] potently and in a concentration-dependent manner (0.3–30 μM) inhibited CRH-CAT activity, whereas its sulfate form was active only at high (30 μM) concentration (Fig. 2A and 2B). Similarly as basal activity, also forskolin-stimulated gene transcription was potently inhibited by PGL (1–30 μM), while PGL-S was inactive in these concentrations (Fig. 2C and 2B)."

"...The 5a-reductase inhibitor – finasteride, at 0.1 and 1 μM did not change the basal CAT activity and had no effect on PGL (1 μM) inhibition of CRH gene promoter activity (Fig. 5)."

"...In the present study, we found that some neurosteroids in a concentration-dependent manner inhibited CRH gene promoter activity in the differentiated Neuro-2A cells. Among investigated neurosteroids, PGL [pregnenolone], the main precursor of steroid hormones, exerted the most potent effect. ALLO and THDOC, two potent endogenous positive modulators of the GABA receptors had only a little weaker inhibitory effect than PGL on CRH activity. It is likely that the inhibitory effect of ALLO and THDOC on CRH gene transcription may be implicated in the mechanism of their anxiolytic action."
I think this study should finally put to rest the arguments and debates of whether pregnenolone raises or lowers cortisol, and how it affects the stress response overall. I posted a similar study, which showed that the pregnenolone metabolites progesterone and allopregannolone potently inhibited ACTH release and thus cortisol synthesis.
Pregnenolone Does Not Boost Cortisol, It Lowers It By 60%

CRH (CRF) is the first step in the manifestation of the stress response. It is a hormone produced in the hypothalamus whenever the organism is under stress, and elevations of CRF/CRH signal the pituitary to produce ACTH, and ACTH signals the adrenals to produce cortisol. Elevated levels of CRF/CRH are found in many diseases, especially "mood" disorders like depression, schizophrenia, PTSD, anxiety, etc. It is well-known that the GABA-ergic system in the brain is one of the natural inhibitors of CRH release and this principle is currently applied in using GABA agonist drugs for treating stress conditions and diseases like Cushing that are characterized by high levels of cortisol.
This study looked at the effect of several steroids on the levels of CRF/CRH. The steroids under study included pregnenolone, allopregnanolone, THDOC, DHEA, and the sulfated derivatives pregnenolone sulfate, and dhea sulfate.
It is already well-known that allopregnanolone and THDOC, both being potent GABA agonists, inhbit CRF/CRH release. What the study found surprising was that pregnenolone itself was the most potent inhibitor of CRF/CRH and it has those effects in relatively low concentrations of 1uM - 30uM range. For the purposes of estimating effects in humans, it is brain levels of pregnenolone that would matter given that CRF/CRH is produced in the brain. Brain levels of pregnenolone are on the order of 100-fold higher than serum levels. I posted a human study in the Pansterone thread showing that a single oral dose of 175mg pregnenolone produced serum levels of 0.5uM in humans and it kept those levels for up to 24 hours. This suggests that the 175mg dose produced brain concentrations of about 50uM. So, to achieve the 30uM concentration found to be most effective for lowering CRF/CRH in the study, one would need about 100mg pregnolone (assuming linear scaling). As many of you here know, Ray has consistently recommended 100mg - 150mg of pregnenolone as a good dose for inhibiting stress, and improving overall health. Given the almost complete absense of studies on pregnenolone bioavailability and pharmacokinetics in humans, the ability of Ray to predict proper dosages of these substances (often decades in advance) is simply astounding!!
One last thing of note is that the steroid allopregnanolone investigated in the study as well is a metabolite of pregnenolone through the progesterone pathways and the activity of the enzyme 5-AR. The scientists suspected that pregnenolone may be inhibiting CRF/CRH through its conversion into allopregnanolone, so they also used the drug finasteride in combination with pregnenolone in order to block its conversion into allopreganolone. Pregnenolone still has the same strong inhibitory effect on CRF/CRH, which means its anti-stress action is intrinsic. That being said, by converting into allopregnanolone as well, pregnenolone may have double anti-stress action - once as an intrinsic effect of pregnenolone, and a second one through the GABA-ergic system activated by its metabolite allopreganolone.
So, pregnenolone is accumulating more and more evidence as one of the primary tools for lowering stress and improving overall health, especially in the brain. Ray recommended to one person over email to combine aspirin and pregnenolone as a potent method to lower cortisol and increase testosterone. I already posted on the ability of aspirin to lower cortisol and increase testosterone on its own, so once again Ray is right on the money.
Aspirin Decreases Cortisol And Increases Testosterone In Humans

Finally, the stress-inhibiting effect of pregnenolone, combined with its ability to raise metabolism, and lower estrogen/cortisol, make it a prime candidate for treating not only mental conditions but also the so-called metabolic syndrome and especially obesity. Both of the latter are conditions almost entirely driven by the CRF/CRH-ACTH-cortisol-estrogen cascade.
Pregnenolone For Obesity And Insulin Resistance
How Pregnenolone And Progesterone Raise Metabolism
Pregnenolone (should) lower estrogen levels

OK, enough of my rant:) Here is the actual study.

Effects of neurosteroids on the human corticotropin-releasing hormone gene. - PubMed - NCBI
"...Corticotropin-releasing hormone (CRH), a peptide synthesized mainly in the paraventricular nuclei (PVN) of the hypothalamus, is a key regulator of hypothalamic-pituitary-adrenal (HPA) axis activity during stress. CRH via pituitary adrenocorticotropic hormone (ACTH) stimulates glucocorticoid synthesis and release from adrenal glands. In turn, glucocorticoids inhibit production of CRH in PVN and ACTH in pituitary by a feedback mechanism. CRH hypersecretion in the central nervous system (CNS) is thought to be an important factor in pathogenesis of some stress-related diseases, such as major depressive disorders, post-traumatic stress disorder (PTSD) or panic disorder [34, 39, 42, 55]. The elevated CRH concentrations in the cerebrospinal fluid and the increased number of CRH-expressing neurons in the hypothalamus have been found in depressed patients [29, 37]. Similarly, the increased CRH concentration or dysregulation of cortisol secretion has been observed in patients with PTSD and panic disorders [11,42]. Also in experimental animals, central administration of CRH or overproduction of this peptide in transgenic mice evoked anxiety, depression, and schizophrenia-like behavior [3, 12, 47]. A large number of preclinical studies have indicated that anxiety-like behavior results from the action of CRH through CRH1 receptor."

"...Apart from CRH1 receptor blockade, another possibility of limiting CRH effect could involve repression of the synthesis of this peptide. Interestingly, although CRH synthesis is augmented by many neurotransmitters and neuropeptides, only two major mechanisms are known to inhibit the HPA axis activity, namely the glucocorticoid negative feedback and the gaminobutyric acid (GABA) [17]. Among compounds acting on GABA receptors, neurosteroids deserve the special attention. Neurosteroids are precursors or metabolites of steroid hormones, which do not show affinities for intracellular steroid hormone receptors, but modulate the action of some membrane receptors, such as GABA, NMDA and sigma-1 [24, 45]. Steroid metabolites with hydroxyl group in the position 3 and with reduced ring A, i.e., allopregnanolone (3a-hydroxy-5a-pregnan20-one, ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are among the most potent allosteric positive modulators of the GABA receptors and exert anxiolytic and antiepileptic activity [7, 9]. Concentrations of ALLO and THDOC are increased in plasma and CNS in response to acute stress and that leads to effect HPA axis activity [14, 36]. Moreover, ALLO and THDOC attenuate the anxiogenic activity of CRH and the methoxamine-stimulated CRH release [33]. Contrary to acute stress, chronic stress decreases brain ALLO concentration and disturbs negative feedback mechanism of HPA regulation."

"...The excitatory neurosteroid, PGL [pregnenolone] potently and in a concentration-dependent manner (0.3–30 μM) inhibited CRH-CAT activity, whereas its sulfate form was active only at high (30 μM) concentration (Fig. 2A and 2B). Similarly as basal activity, also forskolin-stimulated gene transcription was potently inhibited by PGL (1–30 μM), while PGL-S was inactive in these concentrations (Fig. 2C and 2B)."

"...The 5a-reductase inhibitor – finasteride, at 0.1 and 1 μM did not change the basal CAT activity and had no effect on PGL (1 μM) inhibition of CRH gene promoter activity (Fig. 5)."

"...In the present study, we found that some neurosteroids in a concentration-dependent manner inhibited CRH gene promoter activity in the differentiated Neuro-2A cells. Among investigated neurosteroids, PGL [pregnenolone], the main precursor of steroid hormones, exerted the most potent effect. ALLO and THDOC, two potent endogenous positive modulators of the GABA receptors had only a little weaker inhibitory effect than PGL on CRH activity. It is likely that the inhibitory effect of ALLO and THDOC on CRH gene transcription may be implicated in the mechanism of their anxiolytic action."

Thank you for this!
 
M

member 6316

Guest
i glanced the thread but pregnenolone is the best inhibitor of CRH assuming crf1 and crf 2 also? So the higher the dosage of pregnenolone the more it will inhibit them? wouldnt it be counterproductive since pregnenolone increases progesterone and more cortisol will be made
 
Last edited by a moderator:

Amberlense

Member
Joined
Aug 2, 2018
Messages
7
I can't imagine taking more than the 50mg i am currently taking and even then i need to space it out to every second day. This amount to me feels like it has lowered my cortisol considerably. Is it possible that some people can achieve the same results in the OP with less than 100mg?
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe
I can't imagine taking more than the 50mg i am currently taking and even then i need to space it out to every second day. This amount to me feels like it has lowered my cortisol considerably. Is it possible that some people can achieve the same results in the OP with less than 100mg?

Most human studies with pregnenolone for mental health issues like depression and bipolar (which are strongly linked with cortisol) showed that 30mg and 50mg daily had benefit but higher doses like 200mg did not. So, there does seem to be a sweet spot for pregnenolone or at least a biphasic dose-response.
 

golder

Member
Joined
May 10, 2018
Messages
2,851
@bzmazu would you be kind enough to let us know if your leukemia is still in remission with your use of Artemisinin? My father has just had some irregular blood work come back and my initial research is pointing to the dreaded leukemia. Thanks so much!
 
B

Braveheart

Guest
@bzmazu would you be kind enough to let us know if your leukemia is still in remission with your use of Artemisinin? My father has just had some irregular blood work come back and my initial research is pointing to the dreaded leukemia. Thanks so much!

Yes, white blood cell count perfect...I will take it forever...a potent anti cancer herb, and it also eradicated all prostate issues that I had....Artemisinin said to kill cancer cells, yeasts, parasites, pathogens like E coli, and viruses.
 
Last edited by a moderator:

AinmAnseo

Member
Forum Supporter
Joined
Sep 20, 2023
Messages
508
Location
USA
Sorry I'm not sure I get your point. I was talking strictly about the relation between high cortisol/CRH in depression and it's possible action as a defensive mechanism against excessive inflammation in depressed patients.

@Orion I would go by feeling ;-) If one weekly dose works for you, so be it. If one dose every two days works, so be it. Ray has taken up to about 1gram of PREG. Anyway it's effects should be cumulative.

In my personal experience taking PREG once the stress response is set isn't as good as taking it before the stress response. After all, PREG can be converted to cortisol. Remember to take it with enough fuel.
What does this line refer to?
"Remember to take it with enough fuel."
 

AinmAnseo

Member
Forum Supporter
Joined
Sep 20, 2023
Messages
508
Location
USA
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

M
Replies
0
Views
1K
member 6316
M
Back
Top Bottom